NAA logo


We've extended the deadline for submission of abstracts!


North American Artery (NAA) welcomes abstracts for oral and poster presentations dealing with clinical research, experimental studies, epidemiology, biomechanical, methodological, and genetic research related to large artery structure and function. The presentation of data at this meeting will provide the opportunity for scientific interaction and discussion with the audience.

Review categories for abstract submissions are:

  • Vascular Function: Pathophysiological Aspects
  • Vascular Function: Organ Involvement
  • Vascular Function: Treatment – antihypertensive drugs, miscellaneous drugs, nutraceuticals, dietary, exercise, other lifestyle factors
  • Vascular Function: Other - role of age, adolescents, sex, ethnicity, inflammation, metabolic, and other research that does not into one of the categories above

You must indicate the review category that your submission falls under in the cover letter.

The NAA will provide a Young Investigator and Best Abstract awards to researchers who are still in training (i.e., students, fellows, etc.) for the best abstract submission among this group.

There will be up to eleven (11) oral presentations selected from the submissions. Six (6) will be selected from junior researchers’ submissions and five (5) from senior researchers.

All presented abstracts will be published in the official syllabus of the Seventh Annual Meeting of North American Artery, scheduled for May 19-20, 2017, on the Society’s website (, and in Artery Research, the Official Journal of the Association for Research into Arterial Structure and Physiology (ARTERY).

Previously published or presented abstracts will not be considered.

Download these instructions DOWNLOAD THESE INSTRUCTIONS

Abstract Size and Presentation

  • The maximum number of words is 300 (excluding the abstract title and authors) plus up to two figures and/or tables.
  • Abstracts may be reduced in size for printing, so all lettering/symbols/lines should be clear and distinct.
  • Abstracts should be typed single-spaced – minimum type size 11 point, with no space between title and body or between paragraphs.  Paragraphs should be indented.  Please use Arial, Times New Roman and Symbol fonts only.
  • Tables should be kept simple and should be inserted as tab-spaced text or Word tables, not pasted from other applications.
  • Abstracts must be submitted electronically in a PC-compatible format, preferably a Microsoft Word document or similar format (i.e. WordPerfect) together with a cover letter (see below) to

Abstract Content

  • Type the title of the abstract and the presenting author’s name and affiliation in capital letters.  Additional authors and their affiliations should be typed in title-case.
  • Abstract text should clearly state Objectives, Methods, Results, and Conclusion.
  • Define all abbreviations the first time they appear in the abstract.
  • Use only generic names of drugs.
  • References should be kept to a minimum and numbered consecutively as they are cited.
  • Proofread the abstract carefully before submitting.

Grading of Abstracts

  • Abstracts will be scored by the members of the Program Committee according to scientific merit and expertise of presentation.
  • Notification of acceptance/declines will be sent to the corresponding author on or about March 31, 2017 via email.
  • The presenting author of accepted abstracts is expected to attend the Annual Meeting to present the abstract and pay the registration fee.
  • The Young Investigator and Best Abstract awards will be presented during the conference.

Cover Letter

All abstracts must be submitted with a cover letter indicating the name of the corresponding author (first, middle, last), Degree, Title, Institution, Street Address, City, State, Postal Code, Telephone, and Email address.  The cover letter must also clearly indicate the review category for your abstract.

The following statements and your signature must be included as part of the cover letter.

  • "The author affirms that the material submitted has not been previously published or presented at any national or international meeting, and any experimentation has been conducted according to a protocol approved by the institutional committee on ethics or, if no such committee exists, that it conforms with the principles of the Declaration of Helsinki of the World Medical Association (Clinical Research.14: 193, 1966).  The undersigned also certifies that all authors named in the abstract have agreed to its submission for presentation at the Seventh Annual Meeting of the North American Artery Society."
  • I understand that my presentation will be included in a conference syllabus and on the North American Artery Society (NAA) website (  I hereby grant NAA permission to publish my abstract as part of the conference materials and on their website.”
  • I understand that my presentation will also be published in Artery Research, the Official Journal of the Association for Research into Arterial Structure and Physiology (ARTERY).  I hereby grant NAA and ARTERY permission to publish my abstract in Artery Research.”

Note: If you do not wish to have your abstract published in Artery Research, substitute the sentence, “I prefer not to have my abstract published in Artery Research” for the above statement.

Cover letter and abstract should be sent via email to


Privacy Policy | Refund Policy

Copyright 2014 North American Artery

Powered by Wild Apricot Membership Software